Prostate-specific membrane antigen (PSMA) PET/CT has been proven to outperform conventional imaging in detecting primary PCa [12–15], and it is an alternative and promising method to detect csPCa missed by mpMRI [16]. Here, FOLH1 is linked to posterior cortical atrophy.